33565-1F-ACAN_1 - ACAN - BioSpherix GMP x2 Isolator System

Notice is hereby given by the University of Ottawa of the intent to enter into a contract with BioSpherix to purchase an isolator system for the purpose of developing cellular therapeutics and biomaterials in an aseptic fashion under strictly controlled environmental conditions.

Suppliers who consider their equipment functional, successfully tested, readily available and fully compliant may submit in writing a statement of specifications to the contact person identified in this Notice, on or before the closing date of this Notice. In the statement of specifications, the supplier must unequivocally demonstrate how their equipment, at minimum, equals, or exceeds the stated requirements.
 
If no other supplier submits a statement of specifications, on or before the closing date of this Notice, the competitive requirements of the University of Ottawa will be considered having been met.
Following notification to any suppliers not successful in unequivocally demonstrating that their statement of specifications equals or exceeds the requirements set out in this Notice, the contract may then be awarded to the pre-identified supplier.